All data are based on the daily closing price as of July 17, 2024
b

Boryung

003850.KO
7.66 USD
0.08
+1.06%

Overview

Last close
7.66 usd
Market cap
504.32M usd
52 week high
10.04 usd
52 week low
5.92 usd
Target price
10.26 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.8804
Price/Book Value
1.3791
Enterprise Value
617.29M usd
EV/Revenue
1.0946
EV/EBITDA
8.5354

Key financials

Revenue TTM
645.51M usd
Gross Profit TTM
222.95M usd
EBITDA TTM
81.43M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
743.80M usd
Net debt
N/A usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top